You are here
Ultima Genomics, Inc.
UEI: DXEVRGJ7MW28
# of Employees: 127
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing
Amount: $1,999,864.00PROJECT SUMMARY Ultima Genomics, Inc. proposes to develop a novel sequencing-by-synthesis (SBS) chemistry that will further leverage the strengths of the companyandapos;s high-throughput sequencing sy ...
SBIRPhase II2020Department of Health and Human Services National Institutes of Health -
Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing
Amount: $299,441.00PROJECT SUMMARY Ultima GenomicsIncproposes to develop a novel high throughput sequencing technology platform that will reduce cost$ Gbasesubstantially compared with state of the art commercial technol ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing
Amount: $1,925,138.00PROJECT SUMMARY Ultima GenomicsIncproposes to develop a novel high throughput sequencing technology platform that will reduce cost$ Gbasesubstantially compared with state of the art commercial technol ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health
